Rituximab-induced serum sickness.
Herishanu
Yair
Y
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D000069283:Rituximab; D012713:Serum Sickness / Q000139:chemically induced* / Q000175:diagnosis
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab